What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?

Raoul Orvieto*, Simion Meltcer, Roy Homburg, Ravit Nahum, Jacob Rabinson, Jacob Ashkenazi

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

In an attempt to evaluate the influence of the GnRH analogue used during controlled ovarian hyperstimulation (COH) on the outcome of IVF cycles of polycystic ovary syndrome (PCOS) patients, we studied 152 IVF cycles. The PCOS patients undergoing COH using the GnRH agonist protocol (n = 50) showed a significantly higher pregnancy rate (36% vs. 19.6%, respectively), compared with the GnRH antagonist protocol (n = 102).

Original languageEnglish
Pages (from-to)1466-1468
Number of pages3
JournalFertility and Sterility
Volume91
Issue number4 SUPPL.
DOIs
StatePublished - Apr 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization?'. Together they form a unique fingerprint.

Cite this